ISMS provides consultancy services at different phases to achieve market access:


By applying our integrated, systematic and fact-based process, consisting of the unmet need determination, product assessment and health care value determination, ISMS provides strategic recommendations for:

New chemical entity selection

Clinical R&D optimization


The multilevel HEOR & market access assessment and thereby identified optimal market access strategy in a broader healthcare setting is translated into materials to substantiate the intrinsic clinical and economical product value, supporting the global roll-out of market access.

Systematic therapeutic landscape review

Value substantiation and communication
e.g value tool kit, global value dossier

Health economic modeling
e.g cost-effectiveness model, budget impact model


ISMS provides services to support local implementation and allow market access realization at launch.

Science and communication
e.g scientific articles, presentations, trainings, congress support

Models and analytics
e.g pricing and forecasting models

Health care compliance (HCC)
e.g e-learnings, quizzes with certification, training materials, employee guides

Practical implementation
e.g ad interim support or slide kit support

HEOR: Health Economics and Outcomes Research

If don’t see the brochure below, please refresh your web page.